This study will examine how physician perception of professional prescription drug communications is influenced by variations in information context, methodologic rigor of the underlying clinical study, and time pressure. We plan to conduct one pretest (N = 158) and one main study (N = 566) not longer than 20 minutes, administered via Internet panel. Using a description of a trial for a fictitious prescription drug, we will vary the context of the information, the methodologic rigor of the information, and the amount of time available to read the information. Participants will view the information and then answer questions about the drug information.
The latest form for Physician Interpretation of Information About Prescription Drugs in Scientific Publications vs. Promotional Pieces expires 2021-09-30 and can be found here.
Document Name |
---|
Justification for No Material/Nonsubstantive Change |
Supporting Statement B |
Supporting Statement A |
Approved without change |
No material or nonsubstantive change to a currently approved collection | 2020-06-02 | |
Approved without change |
New collection (Request for a new OMB Control Number) | 2019-08-08 |
Federal Enterprise Architecture: Health - Health Care Services